DM PublH 2002

download DM PublH 2002

of 38

Transcript of DM PublH 2002

  • 8/13/2019 DM PublH 2002

    1/38

    Diabetes Mellitus in the

    Pacific:Public Health Issues

    Dr. Kimberly OmanFiji School of MedicineDiploma in Medicine

    Revised September 2002

  • 8/13/2019 DM PublH 2002

    2/38

  • 8/13/2019 DM PublH 2002

    3/38

    Epidemiology of Type I Diabetes

    Country Prevalence per 1000

    Finland 2.2

    USA 1.0UK 0.7

    France 0.24

    India 0.060.7China 0.09

    Japan 0.03

    Tropical Africa 0.03

  • 8/13/2019 DM PublH 2002

    4/38

    II Diabetes age 30-64 (downloaded

    WHO 1998)

    Country of origin Group %men %womenUSA white 5 7.2

    India S India rural 3.7 1.7

    S India urban 11.8 11.2

    Durban SA 14.4 20.8

    Dar es Salam Tanzania Hindu 17.8 13.2

    Dar es Salam Tanzania

    Muslim

    18.0 16.6

    Fiji - Indofijian Rural (Sigatoka) 23.0 16.0

    Urban (Suva) 23.6 20.3

    Fiji - Indigenous Rural (Sigatoka 2.1 1.7

    Urban (Suva) 5.2 11.9

  • 8/13/2019 DM PublH 2002

    5/38

    Country of origin Group %men %women

    Papua New Guinea Highlanders rural 0 0

    Highlands periurban 0 0

    Costal rural 2.7 0

    Costal periurban 8.2 4.8

    New Caledonia 0-2.5 2.3-3.3

    Kiribati Rural 4.0 4.6

    Urban 15.8 13.4

    Nauru 40.6 42.0

    Tuvalu Funafuti 1.3 6.3Western Samoa Rural 2.1 4.9

    Urban 10.7 10.4

    Niue 7.9 10.4

    Cook Islands 7.0 10.1

  • 8/13/2019 DM PublH 2002

    6/38

    Complications of DiabetesMellitus

    Hypoglycemia Diabetic ketoacidosis / hyperosmolar coma Retinopathy Nephropathy Neuropathy

    peripheral neuropathy autonomic neuropathy

    Amputations Macrovascular disease (strokes, ischemic

    heart disease)

  • 8/13/2019 DM PublH 2002

    7/38

    Diabetes Mellitus:Burden of disease to the individual

    Being diagnosed as sick despitefeeling well

    Doctor visits Need to take medications

    Complications Blindness Amputations Heart attacks and stroke

    General unwellness Premature death

  • 8/13/2019 DM PublH 2002

    8/38

    Diabetes Mellitus:Burden of disease to the family

    Premature disability (especially strokes,amputations, blindness) Loss of income

    Loss of productivity: childcare, domestic duties Need for family to care for unwell individual(loss of employment opportunities)

    Transporting patient for clinic visits

    Premature death Loss / grief

  • 8/13/2019 DM PublH 2002

    9/38

    Diabetes: Burden to the Nation(1)

    Need for clinic visitsfor glycemic control Patient education

    Insulin

    Oral hypoglycemicagents

    Related conditions(CAD, HTN,

    hyperlipidemia)

    Doctors, nurses, healthcentres, lab support Dieticians, health

    educators, TIME Refrigerators, syringes,

    Education!! Reliable drug distribution

    infrastructure Expensive drugs,

    hospitals, Coronary careunits

  • 8/13/2019 DM PublH 2002

    10/38

    Diabetes: Burden to the Nation (2)

    Nephropathy Retinopathy

    Amputations

    Early infirmity

    Premature death

    Dialysis ($$$$$) Opthamologists,

    laser machines Surgeons, hospitals,

    antibiotics,prostheses

    Loss of taxableincome, need forhome carers,

    pensions

  • 8/13/2019 DM PublH 2002

    11/38

    Natural history vs. clinical course ofdisease for Type I Diabetes (1)

    Time Disease manifestations

    Week one

    NATURAL HISTORY

    STARTS HERE

    Polydipsia, polyphagia, polyuria

    DKA: DIAGNOSIS MADE

    Insulin started

    CLINICAL COURSE STARTS

    HERE

    Rest of patients life Hypoglycemia (occasional)

    Hyperglycemia / DKA (with

    intercurrent illness

  • 8/13/2019 DM PublH 2002

    12/38

    Natural history vs. clinical course ofdisease for Type I Diabetes (2)

    Natural history = clinical course of dz

    Time Disease manifestations

    After decades Retinopathy, Nephropathy,

    Peripheral Neuropathy,

    Cardiovascular Disease

    Then Blindness, renal failure,amputations, heart attacks,

    strokes

    DEATH

  • 8/13/2019 DM PublH 2002

    13/38

    Natural history vs. clinical course ofdisease for Type II Diabetes (1)

    Age Manifestations

    Age 25 (does natural

    history start even earlier?)

    Undiagnosed gestational diabetes

    Several large infants by c-section

    Age 30 Undiagnosed glucose intolerance

    Age 35 Takes up a sedentary job

    Coworkers bring in sweets everyday

    Becomes obese

    Age 40 Overt diabetes (by fasting blood

    glucose) but no one checked

  • 8/13/2019 DM PublH 2002

    14/38

    Natural history vs.clinical course of disease for Type II Diabetes (2)

    Age Manifestations

    Age 55 Hospitalized for MI

    Raised random blood glucose discovered

    Elevated serum creatinine

    No one checked fundi

    DIAGNOSIS MADE

    CLINICAL COURSE STARTS HERE

    Age 55-59 Starts diet therapy

    Fails to lose weight

    Started on oral hypoglycemic agents

    Poor compliance

    Natural history vs clinical course of disease

  • 8/13/2019 DM PublH 2002

    15/38

    Natural history vs. clinical course of diseasefor Type II Diabetes (3)

    Natural history much longer than clinicalcourse

    Age Manifestations

    Age 60 Congestive heart failure

    Foot ulcer leads to amputation

    Complains of poor vision

    Advanced retinopathy noted

    Age 62 DIESof 3rdmyocardial infarction

  • 8/13/2019 DM PublH 2002

    16/38

    Reducing the burden of disease dueto diabetes mellitus

    Primary prevention Prevent diabetes from developing

    Secondary prevention Early diagnosis Control of blood sugar - does this reducecomplications?

    YES! - first demonstrated in 1998 forType 2

    Tertiary prevention Recognizing complications at early treatable stage

  • 8/13/2019 DM PublH 2002

    17/38

    Diabetes in the United States

    Plenty of doctors and dieticians Plenty of specialists Diabetes educators Many educated and highly motivated patients Self-help groups for patients

    Home glucose monitoring is widespread BUT

    Many patients not educated about their diabetes Cultural, language and financial barriers Many doctors who communicate poorly Many poorly-controlled diabetics

  • 8/13/2019 DM PublH 2002

    18/38

    Diabetes in Ethiopia

    Very impoverished nation

    85% live in isolated rural areas

    Few drugs, poor access to health clinics

    Terrible or nonexistent roads Limited diagnostic capability

    Many other serious health problems

    75% of diagnosed rural diabetics are Type

    One: WHY?

  • 8/13/2019 DM PublH 2002

    19/38

    Type one diabetes in Ethiopia

    Most must travel 20km to get insulin supplies(poor or non-existent roads) 1/4 must travel over 100 km (3-5 day journey) Often short supplies - only given 1-2 months

    insulin Use minimal insulin to survive (to conserve

    supplies) leading to severe wasting Few long-term survivors

    Type 2 diabetics: why bother?

  • 8/13/2019 DM PublH 2002

    20/38

    Diabetes in the Pacific

    Many diabetics

    Limited public awareness of diabetes

    Fewer resources

    Understaffed, very busy clinics Not enough doctors, dieticians and nurses

    Problems with distribution of medicationsand supplies

    Problems with remoteness andtransportation

    B i i i i

  • 8/13/2019 DM PublH 2002

    21/38

    Basic exercise in economics:A trip to Cost-u-Less

    How much does a television cost? a small radio? Which will you buy:

    If the bill comes to you? If the bill comes to daddy?

    If Daddy has 10 children and they buy expensivethings every week, what will happen whenDaddy goes broke?

    No schooling House and car repossessed by the bank No food ETC ETC

    H lth i i i

  • 8/13/2019 DM PublH 2002

    22/38

    Health economic issues inDiabetes Mellitus

    Should you spend 10x as much for a medication If there is significant benefit? If there is marginal / equivocal benefit? If it is only available in the major centers?

    What are the relative costs of health care

    worker time compared with medications? If you spend health resources on world-class

    care for your own patients, will less be availablefor patients in remote settings?

    Is it ethical to spend more health resources on

    some patients than others? (ie. the articulate,the educated, the prominent, etc.)

  • 8/13/2019 DM PublH 2002

    23/38

    Approaches to lowering the burden ofdisease due to diabetes

    International

    Regional (Pacific Islands)

    National

    Provincial District

    Local Hospital

    Health Centre

    Community

  • 8/13/2019 DM PublH 2002

    24/38

  • 8/13/2019 DM PublH 2002

    25/38

    Medication costs (Fijian $) 1996

    Glibenclamide 5 mg Glipizide 5 mg Tolbutamide 500 mg Metformin 850 mg Isophane insulin 10 U Syringes (one) - 1 ml HCTZ 50 mg Atenolol 50 mg Propranolol 40 mg Captopril 12.5 mg Pravastatin 10 mg (BNF-97)

    Home glucose monitor Test strips (50)

    $0.006 $0.07 $0.01 $0.04 $0.12 $0.10 $0.005 $0.04 $0.01 $0.07 $1.73

    $43.00 $35.00

  • 8/13/2019 DM PublH 2002

    26/38

    National level decision making (1) Should all diabetic patients be monitoredwith HbA1C 4 times a year? Cost (1999)

    $10 per test (excluding transport costs) 30,000 diabetics in Fiji $10/test x 4 tests per year x 30,000 = 1.2 milliondollars!

    Moral issue If transporting lab specimens outside of the majorcenters is a problem, is it ethical to only test atmajor centers?

  • 8/13/2019 DM PublH 2002

    27/38

    p ons or spen ng m on

  • 8/13/2019 DM PublH 2002

    28/38

    p ons or spen ng . m onto lower the disease burden from

    Diabetes mellitus (1)

    Health care workers $10k/yr($5/hr)

    Health care workers $20k/yr($10/hr)

    Health care workers $60k/yr($30/hr)

    (dieticians, doctors, nurses,community workers, educators)

    Overseas expert visits (20 days @

    $1000/day) 4-wheel drive vehicles ($50,000) Boats for island visits ($25,000)

    120 HCWs 60 HCWs 20 HCWs

    30 visits

    24 cars 48 boats

    m on o ower e sease

  • 8/13/2019 DM PublH 2002

    29/38

    m on o ower e seaseburden from Diabetes mellitus

    (2)

    Diabetic education and treatment options 120 HCWs x 1940 hours/HCW/yr / 30,000diabetics = 7.8 hrs/diabetic/yr

    Television and radio commercials Educational program in the schools

    Other community awareness programs

    Hemodialysis ($50,000/yr) - 24 patients(which ones???) (???CAPD)

    Laser machine to treat retinopathy (?cost)

  • 8/13/2019 DM PublH 2002

    30/38

    National level decision making (3)

    How often should diabetic patients seea doctor?

    Assumptions: 30,000 diabetics in Fiji

    10 minutes per visit Sample calculation: monthly visits 30,000 x 12 visits/yr x 1/6 hr/visit x

    1920 hours/yr/doctor (40-hr week) Need 31 doctor full-time equivalents

    (FTEs)

    National level decision making

  • 8/13/2019 DM PublH 2002

    31/38

    National level decision making(4)

    How often should diabetic patients see adoctor? (2) Summary

    Monthly visits: 31 doctor FTEs Every 2 months: 16 doctor FTEs

    Every 3 months: 10 doctor FTEs OR: see patients monthly for 3 minutes: 10 doctorFTEs

    How do you get extra doctor FTEs? Work existing doctors harder for the same pay

    (leading to migration, loss to private practice)

    Recruit doctors from overseas Train nurses and nurse practitioners

  • 8/13/2019 DM PublH 2002

    32/38

    National level decision making (5)

    What is the economic impact of replacingtolbutamide with glipizide?

    Assumptions: Tolbutamide 500 mg po tds: $11/yr

    Glipizide 5 mg po bd: $51/yr

    Assume 10% of diabetics on glipizide

    30,000 diabetics in Fiji

    Estimated cost to Fiji per year: $112,000

  • 8/13/2019 DM PublH 2002

    33/38

    Yearly $ of ideal diabetic control(Fiji health budget: $26/head)

    Metformin 850 mg po tds Isophane Insulin 25U nocte Enalapril 20 mg po daily Lovastatin 10 mg po daily

    ($8/m) Home glucose monitor (1/5

    of total cost per year) Test strips (2x/wk) HbA1C 4x/year PLUS clinic visits, dieticians,

    lab tests, specialist servicesfor complications, etc.

    $44 $190 $29 (2002) $96 (2002)

    $9

    $73 $40 Total: $481 ($385

    without statins)

    i h b d f di

  • 8/13/2019 DM PublH 2002

    34/38

    Lessening the burden of disease atthe national level - resource

    allocation (1)

    Development of treatment guidelines Based on evidence

    Economic analysis Epidemiology (determining # of

    diabetics) Education / training of health care

    workers Initial training Continuing medical education / in-servicetraining

  • 8/13/2019 DM PublH 2002

    35/38

    Lessening the burden of disease atthe national level - resource

    allocation (2)

    Hiring more staff

    Medications

    Equipment

    Laboratory support

    Transportation Facilities to treat complications

  • 8/13/2019 DM PublH 2002

    36/38

    Lessening the burden of diabetes mellitus at thelocal level

    (hospital and/or district level)

    More effective clinic visits Evidence-based practice More time with patients

    Organize support services Dieticians Diabetic educators

    Empower other doctors and health care

    workers Teaching Evidence-based guidelines and protocols

  • 8/13/2019 DM PublH 2002

    37/38

    Issues for Fiji (exercises) Metformin is more expensive than

    sulphonourea medications. Is it worth the

    extra cost?

  • 8/13/2019 DM PublH 2002

    38/38

    Rules: confine your search to: Cochrane Collaboration

    New England Journal of Medicine Annals of Internal Medicine ACP Journal Club Lancet British Medical Journal

    Journal of the American Medical Association Medical Journal of Australia Journal Watch (General Internal Medicine) No internet surfing (except major guidelines) Recent textbooks including UpToDate

    Clinical evidence